Accessible and Affordable: Generic Eliquis® (apixaban) Now Available!

Key Takeaways

• Patients eagerly await the availability of a generic version of apixaban as a more affordable alternative to Eliquis.

• The high cost of Eliquis poses a significant financial burden for many patients, with out-of-pocket expenses averaging around $600 per month.

• Patients are encouraged to explore savings programs, discounts, and reputable online Canadian pharmacies as potential cost-saving options.

• The FDA approval of a generic version of Eliquis offers a promising solution for patients, although it won't be available until April 2028. Patients should consult healthcare providers for guidance on obtaining the medication from legitimate sources and stay informed about updates.

Availability of Generic Eliquis

The availability of a generic version of Eliquis - known as apixaban in its generic form - is eagerly awaited by patients seeking a more affordable alternative to the high-cost medication. Currently, Eliquis is the only approved anticoagulant medication in its class, making it the go-to option for patients with conditions such as atrial fibrillation and deep vein thrombosis. However, the high cost of Eliquis poses a significant financial burden for many patients, especially those without insurance coverage or with high-deductible plans.

see this link

The availability of apixaban would provide much-needed relief for these patients. Generic medications are typically priced significantly lower than their brand-name counterparts, making them more accessible and affordable for individuals with limited financial resources. Additionally, approving a generic version of apixaban would introduce competition into the market, potentially driving down the overall cost of the medication even further.

Unfortunately, the generic version of apixaban is not yet available. The patent restoration and extension granted to Bristol Myers Squibb and Pfizer have delayed the entry of generic apixaban until April 2028. This delay prolongs the financial strain on patients who rely on Eliquis, emphasizing the need for lawmakers and regulatory bodies to address the issue of high drug prices and expedite the availability of generic alternatives. Patients deserve access to affordable medications that can improve their quality of life without causing financial hardship.

Cost and Savings of Apixaban

With the high retail price of Eliquis and the delayed availability of generic apixaban, patients are seeking cost-effective alternatives to manage their medical conditions. The current cost of Eliquis poses a significant financial burden for patients, with out-of-pocket expenses averaging around $600 per month. This high cost can make it difficult for individuals to afford the medication they need to maintain their health and well-being.

While the availability date of a generic version of Apixaban could potentially reduce the cost, unfortunately, it won't be available until April 2028 due to a patent restoration and extension in the US. This delay prolongs the financial strain on patients relying on Eliquis for treatment.

To mitigate the high cost of prescribed Eliquis, patients are encouraged to explore savings programs and discounts offered by pharmaceutical companies or consult their healthcare providers and insurance providers to explore cost-saving options. Additionally, it may be beneficial for patients to consider ordering Eliquis or generic apixaban from reputable online Canadian pharmacies, where the medication cost may be significantly lower.

FDA Approval of Generic Eliquis

The FDA's approval of a generic version of Eliquis, presents a promising solution for patients seeking a more cost-effective alternative to this high-priced medication. The availability of a generic variant could significantly alleviate the financial strain on patients who depend on this drug. However, it's essential to recognize that the generic apixaban won't be accessible until April 2028. This delay stems from a patent restoration and extension granted to Bristol Myers Squibb and Pfizer, the manufacturers of Eliquis. Unfortunately, patients will have to endure several more years before they can access a more economical option.

During this interim period, patients must exercise caution and procure medications from reputable sources. Illicit generic versions of Eliquis peddled online may pose safety risks and could be counterfeit. Patients are strongly advised to consult their healthcare providers for guidance on acquiring medication from legitimate sources.

Once the generic version of Eliquis becomes available, it is expected to offer potential cost savings for consumers. This will help alleviate the issue of Eliquis's high cost, ensuring that patients have access to the medication they need without enduring significant financial strain. However, until April 2028, patients will persist in facing the challenges associated with Eliquis's steep price.

Generic Eliquis Prices

While patients eagerly await the availability of a more affordable alternative to Eliquis, it is crucial to delve into the pricing of the generic version, known as apixaban. The cost of Eliquis can impose a significant burden, with out-of-pocket expenses soaring to around $600 per month. This financial strain underscores the pressing need for a generic option to assist patients in managing and mitigating the exorbitant costs linked to this medication. Regrettably, the generic version of Eliquis won't be accessible until April 2028, owing to a patent restoration and extension granted to Bristol Myers Squibb and Pfizer.

The availability of generic Eliquis, or apixaban, could significantly reduce the financial burden on patients. However, it is crucial to be cautious when purchasing medications and only obtain them from reputable and valid sources like Planet Drug Direct.

It is worth noting that the cost of Eliquis can vary depending on factors such as insurance coverage, pharmacy used, and available savings programs. Patients should explore potential savings programs that may be available for Eliquis.

Availability of Eliquis from Trusted Sources

Patients seeking Eliquis from trusted sources should exercise caution and ensure they purchase the medication only from reputable and validated pharmacies. With the availability of a generic version of Eliquis still a few years away, patients must be vigilant when purchasing this medication online. Counterfeit and unsafe versions of Eliquis may be present in illegal online pharmacies, making it essential to buy from trustworthy sources.

Eliquis is a prescription-only drug used to prevent blood clots and treat various heart conditions. It is important to consult a healthcare provider for personalized information and advice before starting this medication. While the cost of Eliquis in the United States is high, there are options to explore cost-saving measures, such as obtaining a 90-day supply, utilizing savings programs, or considering alternatives after consulting a doctor.

It is worth noting that the availability of generic apixaban may vary by country. Generic versions of Eliquis are available in Canada and internationally but are still not available in the United States. Patients should stay informed about the availability of the generic version and consult their healthcare provider or pharmacist for the latest updates from generic manufacturers.

Benefits of Generic Eliquis

Generic Eliquis offers numerous benefits for patients seeking an affordable alternative to the brand-name medication. Patients with nonvalvular atrial fibrillation and other cardiac conditions have the option to use generic Eliquis, also known as generic apixaban, to reduce the risk of developing blood clots. It provides benefits similar to brand-name Eliquis, helping to prevent blood clot formation and treat and prevent blood clots in the legs and lungs. Compared to previous drugs like warfarin, Eliquis is easier to use, with fewer instances of brain bleeding. Furthermore, generic Eliquis is available internationally through Planetdrugdirect.com; we partner with government-approved dispensaries to ship to countries around the globe, including the US, UK, Australia, New Zealand, France, Spain, Switzerland, and more. This accessibility allows patients to save significantly on the cost of medication, providing them with an affordable option to treat blood clots, ensuring well-being and financial stability.

Cost Comparison: Eliquis Vs. Generic Apixaban

In terms of affordability, comparing the cost of Eliquis to its generic counterpart, Apixaban, is crucial for patients seeking a more cost-effective medication option. Currently, Eliquis is quite expensive in the United States, with patients paying around $315.00 for a thirty-day supply or $10.50 per pill. However, a more affordable alternative is available through Canadian mail-order pharmacies or government-approved dispensaries from PlanetDrugsDirect.com. Generic Apixaban can be purchased for around $70.99 for a one-month supply or $1.18 per pill. This substantial price difference allows American patients to save significantly by purchasing either Eliquis or its generic version from reputable sources. While the exact cost of generic apixaban in the United States is still uncertain due to patent extensions, patients can still access lower-cost apixaban from PlanetDrugsDirect.com through a Canadian mail-order pharmacy or a government-approved dispensary that can fulfill their prescription at a discount.

Timeline for Generic Eliquis in America

Approval for the generic version of Eliquis, known as generic apixaban, was granted in the United States in December 2019, with plans to produce affordable generics soon after. However, supply chain issues and patent extensions have caused delays in the availability of generic apixaban in America. The exact cost of generic apixaban in the United States is still uncertain. In the meantime, American patients can source lower-cost apixaban from international online Canadian pharmacies. It is important to note that the approval process for generic drugs involves rigorous testing to ensure safety and efficacy. While generics can be a cost-effective option for many patients, some physicians may prefer to prescribe brand-name drugs in certain situations. Ultimately, patients should have access to low-cost brand-name and generic drugs to meet their healthcare needs.

Drug Approval Process and Considerations

Approving prescription drugs involves rigorous testing and analysis to ensure their safety and efficacy. New drugs undergo a series of preclinical and clinical trials. Preclinical trials involve testing on animals, while clinical trials require recruiting volunteers and designing safe studies. The data obtained from these trials is then analyzed and compiled for submission to the FDA. The FDA review process can take around ten months. Generic drugs, on the other hand, can bypass clinical trials and undergo an Abbreviated New Drug Application (ANDA) process. However, generic drug manufacturers must still conduct testing to ensure safety and efficacy. This includes demonstrating drug efficacy and similarity in onset of action. It's important to note that approval for generic drugs can still face challenges from brand-name patent holders. Therefore, the availability of generic apixaban in the US is uncertain due to patent extensions. In certain situations, physicians may prefer to prescribe brand-name drugs, and patients should have access to low-cost brand-name and generic drugs to ensure their healthcare needs are met.